Polydex Pharmaceuticals Stock Price, News & Analysis
Company Description
Polydex Pharmaceuticals (OTC: POLXF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $6.8M.
POLXF stock has declined 100.0% over the past year.
This page provides a comprehensive overview of POLXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Polydex Pharmaceuticals (POLXF) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $6.8M, POLXF is classified as a micro-cap stock with approximately 3.4M shares outstanding.
Latest News
Polydex Pharmaceuticals has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all POLXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
POLXF Company Profile & Sector Positioning
Polydex Pharmaceuticals (POLXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing POLXF often look at related companies in the same sector, including Aim Immunotech (AIM), Pharmacyte Biotech Inc (PMCB), Cardio Diagnostics Holdings Inc (CDIO), CERo Therapeutics (CERO), and Artelo Biosciences Inc (ARTL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POLXF's relative position within its industry.